RE:RE:Update on Phase II Bladder CancerThis release is pretty much irrelevant to us. Likely for PP purposes only. All good info. The numbers look great. We're all here and excited because of the results like this. I am wondering where the BTD submission is. Results are more than good enough to submit. There are enough evaluable patients for the FDA to review. I'd like to see an update telling us where they are with BTD. I personally would NOT participate in a PP unless I knew the FDA had the data as requested and was reviewing it. We've all read that the FDA had given them guidance on how to present the data. I'd want to know what if any criteria is still missing.